Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose bioequivalence study of Febuxostat 80 mg tablets under fasting conditions in healthy volunteers
TCTR20200916003Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of febuxostat in hyperuricemia (2 arms), sponsored by Bio-innova. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
febuxostat
03
Conditions
hyperuricemia
Beyond the preview
Go deeper on TCTR20200916003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200916003.